Skip to main content
TipRanks
Go Ultimate75% OFF

Hana Pharm Co., Ltd. (293480) Ratios

Hana Pharm Co., Ltd. Ratios

KR:293480's free cash flow for Q2 2026 was ₩-9.74B. For the 2026 fiscal year, KR:293480's free cash flow was decreased by ₩-16.65B and operating cash flow was ₩6.91B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.843.331.822.323.44
Quick Ratio0.931.840.961.392.44
Cash Ratio0.150.270.030.280.16
Solvency Ratio0.190.400.430.400.65
Operating Cash Flow Ratio0.140.790.330.690.63
Short-Term Operating Cash Flow Coverage0.277.230.792.963.06
Net Current Asset Valueâ‚© 13.08Bâ‚© 33.16Bâ‚© 32.02Bâ‚© 25.96Bâ‚© 88.86B
Leverage Ratios
Debt-to-Assets Ratio0.140.080.080.100.04
Debt-to-Equity Ratio0.190.090.100.130.04
Debt-to-Capital Ratio0.160.090.090.110.04
Long-Term Debt-to-Capital Ratio0.070.070.010.070.00
Financial Leverage Ratio1.331.241.251.291.20
Debt Service Coverage Ratio0.828.211.242.844.01
Interest Coverage Ratio0.000.000.0053.22796.89
Debt to Market Cap0.280.140.100.100.02
Interest Debt Per Share3303.871683.761533.792005.05648.52
Net Debt to EBITDA1.320.630.720.570.10
Profitability Margins
Gross Profit Margin61.12%62.70%62.19%62.24%66.61%
EBIT Margin10.82%11.16%12.04%14.85%18.27%
EBITDA Margin15.43%14.59%15.45%17.90%21.21%
Operating Profit Margin10.82%11.16%12.04%14.78%18.33%
Pretax Profit Margin7.67%11.27%12.43%14.57%18.25%
Net Profit Margin3.67%9.43%9.95%11.53%14.26%
Continuous Operations Profit Margin3.67%9.43%9.95%11.53%14.26%
Net Income Per EBT47.76%83.68%80.03%79.13%78.15%
EBT Per EBIT70.91%100.95%103.24%98.55%99.55%
Return on Assets (ROA)2.10%5.56%6.41%7.03%9.23%
Return on Equity (ROE)2.80%6.87%8.03%9.06%11.12%
Return on Capital Employed (ROCE)7.32%7.18%9.25%10.35%13.71%
Return on Invested Capital (ROIC)3.20%5.93%6.82%7.87%10.34%
Return on Tangible Assets2.19%5.80%6.69%7.28%9.64%
Earnings Yield4.40%11.27%8.98%7.89%8.33%
Efficiency Ratios
Receivables Turnover5.225.214.864.764.59
Payables Turnover13.7912.6313.169.879.82
Inventory Turnover1.601.771.761.921.61
Fixed Asset Turnover1.151.211.421.391.60
Asset Turnover0.570.590.640.610.65
Working Capital Turnover Ratio3.753.744.272.661.84
Cash Conversion Cycle271.12247.15255.27229.57268.79
Days of Sales Outstanding69.9670.0675.0776.7079.50
Days of Inventory Outstanding227.62206.00207.92189.84226.45
Days of Payables Outstanding26.4628.9127.7336.9737.16
Operating Cycle297.58276.06283.00266.54305.96
Cash Flow Ratios
Operating Cash Flow Per Share516.301462.421063.861785.281537.70
Free Cash Flow Per Share-1118.06698.91215.06-282.56-548.73
Dividend Paid and CapEx Coverage Ratio0.241.150.780.690.60
Capital Expenditure Coverage Ratio0.321.921.250.860.74
Operating Cash Flow Coverage Ratio0.160.870.690.912.38
Operating Cash Flow to Sales Ratio0.040.110.080.150.13
Free Cash Flow Yield-9.96%6.41%1.50%-1.59%-2.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio22.138.8611.1412.6712.00
Price-to-Sales (P/S) Ratio0.830.841.111.461.71
Price-to-Book (P/B) Ratio0.640.610.891.151.33
Price-to-Free Cash Flow (P/FCF) Ratio-10.0415.6066.87-63.00-36.72
Price-to-Operating Cash Flow Ratio21.737.4513.529.9713.10
Price-to-Earnings Growth (PEG) Ratio-0.38-1.89-1.37-0.780.13
Enterprise Value Multiple6.726.367.908.738.17
Enterprise Value248.29B209.17B273.87B329.47B340.34B
EV to EBITDA6.726.367.908.738.17
EV to Sales1.040.931.221.561.73
EV to Free Cash Flow-12.5017.3073.61-67.41-37.18
EV to Operating Cash Flow27.068.2714.8810.6713.27
Tangible Book Value Per Share16621.3816961.9615236.8814822.0614328.92
Shareholders’ Equity Per Share17633.9817872.4916069.4215515.1715098.36
Tax and Other Ratios
Effective Tax Rate0.520.160.200.210.22
Revenue Per Share13475.7413026.1812975.1312188.2811772.15
Net Income Per Share493.901228.401290.991405.121679.08
Tax Burden0.480.840.800.790.78
Interest Burden0.711.011.030.981.00
Research & Development to Revenue0.060.040.030.020.02
SG&A to Revenue0.240.250.250.230.21
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.051.190.821.270.92

Currency in KRW